Generic Name : Rimonabant Therapeutic Classification : Antiobesity Drug ICD Code : Y52.6
International- Acomplia, Bethin, Monaslim, Remonabent, Riobant, Slimona, Rimoslim, Zimulti, and Riomont. Why it is prescribed (Indications) :
This medication is an anorectic anti-obesity agent, prescribed for obesity and management of body weight as adjunct to diet and exercise. It blocks endogenous cannabinoid binding to neuronal CB1 receptors. When it is not to be taken (Contraindications): Hypersensitivity.
Dosage & When it is to be taken :
PO- The usual dose is one 20mg tablet to be taken once daily. How it should be taken :
It comes as a tablet to take by mouth, before breakfast. Warnings and Precautions :
* Caution should be exercised in patients with history of liver or kidney impairment, epilepsy, who are taking other medications, any allergy, during pregnancy and breastfeeding.
* It may cause dizziness, do not drive a car or operate machinery while taking this medication. Side Effects :
Gastrointestinal - Nausea, loss of appetite, dry mouth, vomiting, gastrointestinal disorders, diarrhea.
Central Nervous System - Dizziness, mood changes, sleep disorder, diarrhea, depression, anxiety, memory loss.
Skin - Itching, excessive sweating.
Musculoskeletal - Muscle cramps or spasm, tendon pain and inflammation, back pain and joint sprain.
* Avoid excess dosage. Storage Conditions :
Store the medication as directed by your physician.
Comment & Contribute
Ask an Expert